Indoco Remedies LimitedNSE: INDOCO

Press Release Aug 13 2025

· Issued by Indoco Remedies Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-13-2025-59

Indoco Remedies Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "Indoco Remedies receives final ANDA approval from USFDA forRivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg".

View Attachment

6ix hasn’t read this filing yet.

Indoco Remedies Limited on 6ix

Earlier from Indoco Remedies

Later from Indoco Remedies

All Indoco Remedies news releases